54 related articles for article (PubMed ID: 16954580)
21. Eptifibatide-eluting stent as an antiproliferative and antithrombotic agent: in vitro evaluation.
Chitkara K; Hogrefe K; Vasa-Nicotera M; Swanson N; Gershlick AH
J Invasive Cardiol; 2006 Sep; 18(9):417-22. PubMed ID: 16954580
[TBL] [Abstract][Full Text] [Related]
22. [Optimal platelet inhibition after coronary stent implantation. Current status].
Silber S; Hoffmeister HM; Bode C
Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
[TBL] [Abstract][Full Text] [Related]
23. Platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary intervention: focus on the pharmacokinetic-pharmacodynamic relationships of eptifibatide.
Gilchrist IC
Clin Pharmacokinet; 2003; 42(8):703-20. PubMed ID: 12846593
[TBL] [Abstract][Full Text] [Related]
24. Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
Waksman R; Pakala R
EuroIntervention; 2009 Dec; 5 Suppl F():F36-42. PubMed ID: 22100674
[TBL] [Abstract][Full Text] [Related]
25. Drug-eluting stent thrombosis: an oversensationalized but unresolved problem?
Latib A; Chieffo A; Colombo A
Monaldi Arch Chest Dis; 2007 Mar; 68(1):1-5. PubMed ID: 17564287
[No Abstract] [Full Text] [Related]
26. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
27. [Expectation for new-generation drug eluting stents].
Saito S
Nihon Rinsho; 2011 Feb; 69(2):237-9. PubMed ID: 21387669
[TBL] [Abstract][Full Text] [Related]
28. Drug-eluting versus bare-metal coronary stents: where are we now?
Amoroso NS; Bangalore S
J Comp Eff Res; 2012 Nov; 1(6):501-8. PubMed ID: 24236469
[TBL] [Abstract][Full Text] [Related]
29. [Drug-eluting stent-associated thrombosis: clinical relevance of impaired vessel-wall healing].
Koziński M; Sukiennik A; Sinkiewicz W; Kochman W; Kubica J
Postepy Hig Med Dosw (Online); 2008 May; 62():185-205. PubMed ID: 18464681
[TBL] [Abstract][Full Text] [Related]
30. New drug-eluting stent platforms to prevent stent thrombosis.
Kereiakes DJ
Rev Cardiovasc Med; 2007; 8 Suppl 1():S34-43. PubMed ID: 17401310
[TBL] [Abstract][Full Text] [Related]
31. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
Grube E; Buellesfeld L
Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
[TBL] [Abstract][Full Text] [Related]
32. Role of adjunct pharmacologic therapy in the era of drug-eluting stents.
Douglas JS
Atheroscler Suppl; 2005 Dec; 6(4):47-52. PubMed ID: 16275124
[TBL] [Abstract][Full Text] [Related]
33. Successful trapping of an organized thrombus in a coronary artery aneurysm in myocardial infarction: case report and literature review.
Härle T; Reimers J; Hertting K; Kuck KH
Cardiovasc Revasc Med; 2008; 9(1):52-5. PubMed ID: 18206639
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
35. Prevention of stent thrombosis following brachytherapy and implantation of drug-eluting stents.
Derntl M; Syeda B; Beran G; Schukro C; Denk S; Glogar D
J Interv Cardiol; 2002 Dec; 15(6):477-83. PubMed ID: 12476651
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable stents as a platform to drug loading.
Tsuji T; Tamai H; Igaki K; Kyo E; Kosuga K; Hata T; Nakamura T; Fujita S; Takeda S; Motohara S; Uehata H
Int J Cardiovasc Intervent; 2003; 5(1):13-6. PubMed ID: 12623560
[TBL] [Abstract][Full Text] [Related]
37. Cardiac tamponade following stent implantation with adjuvant platelet IIb/IIIa receptor inhibitor administration.
Bottner RK; Hardigan KR
Cathet Cardiovasc Diagn; 1997 Apr; 40(4):380-2. PubMed ID: 9096940
[TBL] [Abstract][Full Text] [Related]
38. Eptifibatide-induced thrombocytopenia: with thrombosis and disseminated intravascular coagulation immediately after left main coronary artery percutaneous coronary angioplasty.
Tempelhof MW; Benzuly KH; Fintel D; Krichavsky MZ
Tex Heart Inst J; 2012; 39(1):86-91. PubMed ID: 22412237
[TBL] [Abstract][Full Text] [Related]
39. The WRIST series--what have we learnt?
Ajani AE; Waksman R
Herz; 2002 Feb; 27(1):23-9. PubMed ID: 11951793
[TBL] [Abstract][Full Text] [Related]
40. Prospects for the use of antagonists to the platelet glycoprotein IIb/IIIa receptor to prevent post-angioplasty restenosis and thrombosis.
Ellis SG; Bates ER; Schaible T; Weisman HF; Pitt B; Topol EJ
J Am Coll Cardiol; 1991 May; 17(6 Suppl B):89B-95B. PubMed ID: 2016487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
